U.S. flag

An official website of the United States government

NM_025207.5(FLAD1):c.797del (p.Glu266fs) AND Myopathy with abnormal lipid metabolism

Germline classification:
Pathogenic (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001542637.2

Allele description [Variation Report for NM_025207.5(FLAD1):c.797del (p.Glu266fs)]

NM_025207.5(FLAD1):c.797del (p.Glu266fs)

Gene:
FLAD1:flavin adenine dinucleotide synthetase 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
1q21.3
Genomic location:
Preferred name:
NM_025207.5(FLAD1):c.797del (p.Glu266fs)
HGVS:
  • NC_000001.11:g.154988529del
  • NG_042310.1:g.10236del
  • NM_001184891.2:c.506del
  • NM_001184892.2:c.500del
  • NM_025207.5:c.797delMANE SELECT
  • NM_201398.3:c.506del
  • NP_001171820.1:p.Glu169fs
  • NP_001171821.1:p.Glu167fs
  • NP_079483.3:p.Glu266fs
  • NP_958800.1:p.Glu169fs
  • NC_000001.10:g.154961005del
Protein change:
E167fs
Links:
dbSNP: rs1657723514
NCBI 1000 Genomes Browser:
rs1657723514
Molecular consequence:
  • NM_001184891.2:c.506del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001184892.2:c.500del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_025207.5:c.797del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_201398.3:c.506del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Myopathy with abnormal lipid metabolism
Synonyms:
Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency
Identifiers:
MONDO: MONDO:0009703; MedGen: C4310822; OMIM: 255100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001759990Genomics England Pilot Project, Genomics England
no assertion criteria provided

(ACGS Guidelines, 2016)
Pathogenicgermlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Genomics England Pilot Project, Genomics England, SCV001759990.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023